- Home
- SNTG vs NLSP Comparison
SNTG vs NLSP Comparison
Compare SNTG & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- NLSP
- Stock Information
- Founded
- SNTG 2009
- NLSP 2015
- Country
- SNTG China
- NLSP Switzerland
- Employees
- SNTG N/A
- NLSP N/A
- Industry
- SNTG Finance: Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- SNTG Finance
- NLSP Health Care
- Exchange
- SNTG Nasdaq
- NLSP Nasdaq
- Market Cap
- SNTG 5.9M
- NLSP 6.2M
- IPO Year
- SNTG 2021
- NLSP 2021
- Fundamental
- Price
- SNTG $1.87
- NLSP $1.95
- Analyst Decision
- SNTG
- NLSP
- Analyst Count
- SNTG 0
- NLSP 0
- Target Price
- SNTG N/A
- NLSP N/A
- AVG Volume (30 Days)
- SNTG 430.5K
- NLSP 6.1M
- Earning Date
- SNTG 12-17-2024
- NLSP 10-18-2024
- Dividend Yield
- SNTG N/A
- NLSP N/A
- EPS Growth
- SNTG N/A
- NLSP N/A
- EPS
- SNTG N/A
- NLSP N/A
- Revenue
- SNTG $146,472.00
- NLSP N/A
- Revenue This Year
- SNTG N/A
- NLSP N/A
- Revenue Next Year
- SNTG N/A
- NLSP N/A
- P/E Ratio
- SNTG N/A
- NLSP N/A
- Revenue Growth
- SNTG N/A
- NLSP N/A
- 52 Week Low
- SNTG $1.65
- NLSP $1.71
- 52 Week High
- SNTG $3.97
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- SNTG 49.72
- NLSP 44.06
- Support Level
- SNTG $1.71
- NLSP $2.14
- Resistance Level
- SNTG $1.96
- NLSP $2.34
- Average True Range (ATR)
- SNTG 0.10
- NLSP 0.24
- MACD
- SNTG -0.00
- NLSP -0.00
- Stochastic Oscillator
- SNTG 62.50
- NLSP 12.07
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.